Tidal Investments’s RxSight RXST Stock Holding History

Tidal Investments’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,331	Closed	-$355K	–	1991
2024 Q4	$355K	Buy	+10,331	New	+$466K	﹤0.01%	1531

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Tidal Investments's RXST Position: Q1 2025 in Review

Tidal Investments sold out of RxSight (RXST) in Q1 2025, closing a stake of 10,331 shares — an estimated $355K sold.

Tidal Investments first reported a position in RXST in Q4 2024 and held it in 1 quarter. The position peaked at $355K in Q4 2024. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

Tidal Investments reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
Tidal Investments sold 10,331 RxSight shares in Q1 2025, an estimated $355K.
Tidal Investments first reported a position in RxSight in Q4 2024 and held it in 1 quarter.
Tidal Investments's RxSight position peaked at $355K in Q4 2024.
192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on Tidal Investments's 13F filing for Q1 2025, filed 14 May 2025.